Market Overview

UPDATE: Piper Jaffray Raises PT on LHC Group on Q4 Earnings, FY13 EPS Guidance

Share:
Related LHCG
Worst Performing Industries For May 10, 2016
Earnings Scheduled For March 2, 2016
InsiderInsights.com Daily Round Up 5/27/16: TEP, CETV, FLKS, EHTH (Seeking Alpha)

In a report published Monday, Piper Jaffray reiterated its Overweight rating on LHC Group (NASDAQ: LHCG), and slightly raised its price target from $21.00 to $22.00.

Piper Jaffray noted, “Organic admissions growth of 5.6% was solid and the company continues to receive an increasing amount of inbound calls about hospital partnership opportunities. Although the recently completely Addus Home Health acquisition is expected to be neutral to FY13 earnings, we believe Addus could approach corporate margins in 2014 and accretion could be in the neighborhood of $0.20-$0.25 assuming 100 bps of overall G&A leverage.”

LHC Group closed on Friday at $20.35.

Latest Ratings for LHCG

DateFirmActionFromTo
Feb 2016SunTrust Robinson HumphreyMaintainsNeutral
Feb 2016JefferiesInitiates Coverage onBuy
Sep 2015Wells FargoInitiates Coverage onOutperform

View More Analyst Ratings for LHCG
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Analyst Ratings

 

Related Articles (LHCG)

View Comments and Join the Discussion!